US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ImmunityBio, Inc.

5.95

-0.6750-10.20%

Post-market: 6.100.1550+2.61%19:59 EST

Volume:39.43M

Turnover:259.58M

Market Cap:5.86B

PE:-14.31

High:7.30

Open:6.62

Low:5.94

Close:6.62

52wk High:8.28

52wk Low:1.83

Shares:984.97M

Float Shares:194.00M

Volume Ratio:2.07

T/O Rate:20.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4153

EPS(LYR):-0.6189

ROE:78.05%

ROA:-36.89%

PB:-11.17

PE(LYR):-9.61

Loading ...

Overview Company News Filings

ImmunityBio call volume above normal and directionally bullish

ImmunityBio call volume above normal and directionally bullish

BTIG Reaffirms Their Buy Rating on ImmunityBio (IBRX)

ImmunityBio Launches Phase 2 Trial of Chemotherapy-Free CAR-NK Cell Therapy for Indolent Lymphomas

Immunitybio Launches Phase 2 Chemotherapy-Free Car-Nk Cell Therapy Trial With Anktiva® (Resq215b) in Indolent Lymphomas

THOMSON REUTERS

Did ANKTIVA’s Expanding Approvals and Chemo‑Free GBM Data Just Shift ImmunityBio’s (IBRX) Investment Narrative?

Simply Wall St.

ImmunityBio Is Maintained at Buy by HC Wainwright & Co.

ImmunityBio Amends Convertible Note to Allow Partial Debt-to-Equity Conversion

Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Brainsway (BWAY)

ImmunityBio Forms Biotech Alliance with Saudi Partners

ImmunityBio Reports Promising Survival Data for ANKTIVA Plus CAR-NK in Recurrent Glioblastoma Trial

Immunitybio Shares Down 2% After Co Reports Mid-Stage Data for Brain Cancer Treatment

THOMSON REUTERS

BUZZ-ImmunityBio releases early brain cancer treatment trial data; shares down

BRIEF-ImmunityBio: Median Overall Survival Unreached, Lymphopenia Reversed In Recurrent Glioblastoma On Anktiva And CAR-NK Chemo-Free Therapy

Immunitybio Inc: Three Participants Experienced Serious Adverse Events Suspected to Be Related to Experimental Therapy

THOMSON REUTERS

Immunitybio Inc: Treatment Regimen Demonstrated a Manageable Safety Profile

THOMSON REUTERS

Immunitybio Reports Median Overall Survival Not yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving Anktiva® Plus Car-Nk, Chemo-Free Therapy

THOMSON REUTERS

ImmunityBio Is Maintained at Buy by BTIG

A Look At ImmunityBio (IBRX) Valuation After FDA Anktiva Pathway And Saudi Approvals

Simply Wall St.

ImmunityBio Director Christobel Selecky Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":5.945,"timestamp":1771016400000,"preClose":6.62,"halted":0,"volume":39433165,"hourTrading":{"tag":"盘后","latestPrice":6.1,"preClose":5.945,"latestTime":"19:59 EST","volume":684623,"amount":4105165.3511,"timestamp":1771030793242,"change":0.155,"changeRate":0.026072,"amplitude":0.026072},"delay":0,"changeRate":-0.10196374622356492,"floatShares":194000000,"shares":984965179,"eps":-0.415322,"marketStatus":"Market Closed","change":-0.675,"latestTime":"02-13 16:00:00 EST","open":6.62,"high":7.3,"low":5.94,"amount":259581762.40720248,"amplitude":0.205438,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.415322,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":6.62,"preHourTrading":{"tag":"盘前","latestPrice":6.64,"preClose":6.62,"latestTime":"09:29 EST","volume":74824,"amount":494547.3574,"timestamp":1770992997076,"change":0.02,"changeRate":0.003021,"amplitude":0.022523},"postHourTrading":{"tag":"盘后","latestPrice":6.1,"preClose":5.945,"latestTime":"19:59 EST","volume":684623,"amount":4105165.3511,"timestamp":1771030793242,"change":0.155,"changeRate":0.026072,"amplitude":0.026072},"volumeRatio":2.069620222524645,"optionData":{"bulkOrders":[{"symbol":"IBRX","call":true,"expireDate":1832043600000,"strike":"2.5","timestamp":1771015104073,"price":4,"volume":1499,"amount":599600,"type":"-"}]},"impliedVol":1.3769,"impliedVolPercentile":0.8805},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRX\",,,,,undefined,":{"symbol":"IBRX","floatShares":194000000,"roa":"-36.89%","roe":"78.05%","lyrEps":-0.618872,"volumeRatio":2.069620222524645,"shares":984965179,"dividePrice":0,"high":7.3,"amplitude":0.205438,"preClose":6.62,"low":5.94,"week52Low":1.83,"pbRate":"-11.17","psRate":"70.93","week52High":8.28,"institutionHeld":0,"latestPrice":5.945,"eps":-0.415322,"divideRate":0,"volume":39433165,"delay":0,"ttmEps":-0.415322,"open":6.62,"prevYearClose":1.98,"prevWeekClose":6.05,"prevMonthClose":6.25,"prevQuarterClose":1.98,"fiveDayClose":6.05,"twentyDayClose":3.95,"sixtyDayClose":2.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-04","symbol":"IBRX","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2025-08-05","symbol":"IBRX","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-05-12","symbol":"IBRX","fiscalQuarterEnding":"2025/03","expectedEps":-0.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2025-03-03","symbol":"IBRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2024-11-12","symbol":"IBRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.18,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1747717200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IBRX","date":"2026-02-13","current":-14.314195,"percent":0.070434,"low":-176.528118,"twenty":-7.881311,"median":-5.922612,"eighty":-4.044605,"high":-1.243325,"avg":-9.630036,"sd":18.310377,"marketCap":6520469484},"quantilePoints":[{"date":"2021-03-12","current":-139.306686,"twenty":-168.00733,"median":-155.226147,"eighty":-145.67447,"marketCap":11697582400},{"date":"2021-03-19","current":-162.133658,"twenty":-163.283607,"median":-156.010378,"eighty":-143.411991,"marketCap":13614363229},{"date":"2021-03-26","current":-122.204879,"twenty":-163.283607,"median":-155.226147,"eighty":-139.817568,"marketCap":10261543689},{"date":"2021-04-01","current":-102.217673,"twenty":-161.111481,"median":-140.959997,"eighty":-114.465541,"marketCap":8583218022},{"date":"2021-04-09","current":-76.982685,"twenty":-156.977141,"median":-136.802141,"eighty":-99.589219,"marketCap":6464236073},{"date":"2021-04-16","current":-79.309963,"twenty":-156.480917,"median":-112.530706,"eighty":-83.02448,"marketCap":6659657554},{"date":"2021-04-23","current":-32.367587,"twenty":-153.711745,"median":-105.275077,"eighty":-77.667178,"marketCap":7180781506},{"date":"2021-04-30","current":-30.648701,"twenty":-146.315311,"median":-85.767016,"eighty":-73.934408,"marketCap":6799444947},{"date":"2021-05-07","current":-28.904747,"twenty":-140.884776,"median":-83.918884,"eighty":-32.405585,"marketCap":6412546953},{"date":"2021-05-14","current":-21.966347,"twenty":-140.328451,"median":-79.309963,"eighty":-30.068534,"marketCap":5808495359},{"date":"2021-05-21","current":-23.069746,"twenty":-138.304868,"median":-77.188033,"eighty":-27.79276,"marketCap":6100263797},{"date":"2021-05-28","current":-25.479802,"twenty":-131.879052,"median":-75.978762,"eighty":-25.629518,"marketCap":6737547492},{"date":"2021-06-04","current":-25.421728,"twenty":-122.204879,"median":-33.38663,"eighty":-25.421728,"marketCap":6722191258},{"date":"2021-06-11","current":-22.053458,"twenty":-112.530706,"median":-32.462582,"eighty":-24.666771,"marketCap":5831529709},{"date":"2021-06-18","current":-19.469182,"twenty":-108.378113,"median":-30.959505,"eighty":-23.171375,"marketCap":5148177314},{"date":"2021-06-25","current":-20.979096,"twenty":-108.33248,"median":-29.845791,"eighty":-22.648713,"marketCap":5547439388},{"date":"2021-07-02","current":-20.311249,"twenty":-102.217673,"median":-28.38674,"eighty":-22.053458,"marketCap":5370842701},{"date":"2021-07-09","current":-18.975556,"twenty":-99.589219,"median":-27.281661,"eighty":-21.539507,"marketCap":5017649328},{"date":"2021-07-16","current":-15.723433,"twenty":-88.400034,"median":-25.992016,"eighty":-20.918118,"marketCap":4157700247},{"date":"2021-07-23","current":-15.694396,"twenty":-85.566232,"median":-25.479802,"eighty":-20.357708,"marketCap":4150022130},{"date":"2021-07-30","current":-15.912172,"twenty":-85.333504,"median":-25.13674,"eighty":-19.765357,"marketCap":4207608006},{"date":"2021-08-06","current":-15.810544,"twenty":-83.097493,"median":-24.666771,"eighty":-18.589367,"marketCap":4180734597},{"date":"2021-08-13","current":-14.606244,"twenty":-82.476885,"median":-23.839222,"eighty":-16.980727,"marketCap":4400510771},{"date":"2021-08-20","current":-12.983328,"twenty":-79.939697,"median":-23.069746,"eighty":-16.466776,"marketCap":3911565130},{"date":"2021-08-27","current":-14.697127,"twenty":-78.871887,"median":-22.721305,"eighty":-16.25771,"marketCap":4427891727},{"date":"2021-09-03","current":-14.216744,"twenty":-77.667178,"median":-22.329308,"eighty":-16.156082,"marketCap":4283163817},{"date":"2021-09-10","current":-12.840511,"twenty":-77.146963,"median":-22.053458,"eighty":-15.871521,"marketCap":3868537913},{"date":"2021-09-17","current":-13.217028,"twenty":-76.681508,"median":-21.661461,"eighty":-15.671167,"marketCap":3981973302},{"date":"2021-09-24","current":-13.320895,"twenty":-76.179546,"median":-21.080725,"eighty":-14.790607,"marketCap":4013265823},{"date":"2021-10-01","current":-12.996311,"twenty":-74.445497,"median":-20.84843,"eighty":-14.663371,"marketCap":3915476695},{"date":"2021-10-08","current":-11.438312,"twenty":-49.401306,"median":-20.674209,"eighty":-14.190778,"marketCap":3446088879},{"date":"2021-10-15","current":-12.074495,"twenty":-33.065373,"median":-20.245916,"eighty":-13.884371,"marketCap":3637755570},{"date":"2021-10-22","current":-10.737212,"twenty":-32.675027,"median":-19.832142,"eighty":-13.217028,"marketCap":3234864362},{"date":"2021-10-29","current":-10.165946,"twenty":-32.443583,"median":-19.222369,"eighty":-12.991118,"marketCap":3062755496},{"date":"2021-11-05","current":-10.905996,"twenty":-31.714708,"median":-18.380301,"eighty":-12.856091,"marketCap":3285714709},{"date":"2021-11-12","current":-9.494002,"twenty":-31.087485,"median":-17.102681,"eighty":-12.653551,"marketCap":3069429810},{"date":"2021-11-19","current":-7.907569,"twenty":-30.773023,"median":-16.594537,"eighty":-12.500348,"marketCap":2556532860},{"date":"2021-11-26","current":-7.993654,"twenty":-30.358617,"median":-16.492909,"eighty":-12.401675,"marketCap":2584364477},{"date":"2021-12-03","current":-7.181991,"twenty":-29.861331,"median":-16.311429,"eighty":-12.035545,"marketCap":2321952084},{"date":"2021-12-10","current":-7.218885,"twenty":-29.422753,"median":-16.246096,"eighty":-11.682398,"marketCap":2333879920},{"date":"2021-12-17","current":-8.042846,"twenty":-28.697544,"median":-16.188022,"eighty":-11.225385,"marketCap":2600268258},{"date":"2021-12-23","current":-8.79302,"twenty":-28.238245,"median":-16.035578,"eighty":-10.989089,"marketCap":2842800925},{"date":"2021-12-31","current":-7.481003,"twenty":-27.571744,"median":-15.810544,"eighty":-10.745002,"marketCap":2418623094},{"date":"2022-01-07","current":-7.70248,"twenty":-27.264394,"median":-15.708914,"eighty":-10.199703,"marketCap":2490227067},{"date":"2022-01-14","current":-8.206955,"twenty":-27.001937,"median":-15.320327,"eighty":-9.686872,"marketCap":2653325006},{"date":"2022-01-21","current":-6.66892,"twenty":-26.228381,"median":-14.800994,"eighty":-8.79302,"marketCap":2156075192},{"date":"2022-01-28","current":-6.361313,"twenty":-25.755651,"median":-14.736077,"eighty":-8.571657,"marketCap":2056625229},{"date":"2022-02-04","current":-6.632007,"twenty":-25.537875,"median":-14.632211,"eighty":-8.067442,"marketCap":2144141196},{"date":"2022-02-11","current":-7.333351,"twenty":-25.479802,"median":-14.411494,"eighty":-7.973174,"marketCap":2370887111},{"date":"2022-02-18","current":-9.117472,"twenty":-25.421728,"median":-14.099894,"eighty":-7.973174,"marketCap":2947696895},{"date":"2022-02-25","current":-8.465345,"twenty":-25.32881,"median":-13.905144,"eighty":-7.972351,"marketCap":2736862974},{"date":"2022-03-04","current":-6.987741,"twenty":-25.035435,"median":-13.333878,"eighty":-7.903464,"marketCap":2423278818},{"date":"2022-03-11","current":-6.895948,"twenty":-24.773455,"median":-13.217028,"eighty":-7.812412,"marketCap":2391445927},{"date":"2022-03-18","current":-6.792681,"twenty":-24.678386,"median":-13.015786,"eighty":-7.748491,"marketCap":2355633925},{"date":"2022-03-25","current":-6.586147,"twenty":-24.202182,"median":-12.983328,"eighty":-7.674619,"marketCap":2284009920},{"date":"2022-04-01","current":-6.666466,"twenty":-23.969888,"median":-12.853495,"eighty":-7.623044,"marketCap":2311863700},{"date":"2022-04-08","current":-5.909174,"twenty":-23.778245,"median":-12.684711,"eighty":-7.515551,"marketCap":2049242350},{"date":"2022-04-14","current":-5.794432,"twenty":-23.397862,"median":-12.645761,"eighty":-7.486065,"marketCap":2009451236},{"date":"2022-04-22","current":-4.853554,"twenty":-23.110398,"median":-12.554878,"eighty":-7.380274,"marketCap":1683164105},{"date":"2022-04-29","current":-4.165107,"twenty":-22.93908,"median":-12.438028,"eighty":-7.213631,"marketCap":1444417423},{"date":"2022-05-06","current":-4.245426,"twenty":-22.817126,"median":-12.262753,"eighty":-7.146326,"marketCap":1472271203},{"date":"2022-05-13","current":-3.75368,"twenty":-22.706787,"median":-12.074495,"eighty":-7.037365,"marketCap":1388869099},{"date":"2022-05-20","current":-4.205412,"twenty":-22.474492,"median":-11.905712,"eighty":-6.99361,"marketCap":1556010939},{"date":"2022-05-27","current":-4.216168,"twenty":-22.340922,"median":-11.594112,"eighty":-6.929147,"marketCap":1559990507},{"date":"2022-06-03","current":-3.925768,"twenty":-22.23639,"median":-11.373395,"eighty":-6.882179,"marketCap":1452542181},{"date":"2022-06-10","current":-3.646125,"twenty":-22.079591,"median":-11.133204,"eighty":-6.774323,"marketCap":1349073423},{"date":"2022-06-17","current":-3.409503,"twenty":-22.018614,"median":-10.970912,"eighty":-6.667448,"marketCap":1261522935},{"date":"2022-06-24","current":-4.4743,"twenty":-21.908273,"median":-10.776162,"eighty":-6.595319,"marketCap":1655500129},{"date":"2022-07-01","current":-4.291456,"twenty":-21.670172,"median":-10.685279,"eighty":-6.508123,"marketCap":1587847480},{"date":"2022-07-08","current":-5.141143,"twenty":-21.646943,"median":-10.425612,"eighty":-6.414035,"marketCap":1902233322},{"date":"2022-07-15","current":-4.839989,"twenty":-21.109762,"median":-10.152963,"eighty":-6.115708,"marketCap":1790805429},{"date":"2022-07-22","current":-4.700167,"twenty":-21.080725,"median":-9.84705,"eighty":-5.794432,"marketCap":1739071049},{"date":"2022-07-29","current":-4.183901,"twenty":-20.979096,"median":-9.265123,"eighty":-5.656743,"marketCap":1548051804},{"date":"2022-08-05","current":-4.829233,"twenty":-20.964577,"median":-9.105168,"eighty":-5.048614,"marketCap":1786825861},{"date":"2022-08-12","current":-4.808304,"twenty":-20.732283,"median":-8.780722,"eighty":-4.926033,"marketCap":1809374559},{"date":"2022-08-19","current":-4.223223,"twenty":-20.732283,"median":-8.678425,"eighty":-4.850856,"marketCap":1589207300},{"date":"2022-08-26","current":-4.350877,"twenty":-20.674209,"median":-8.625301,"eighty":-4.818477,"marketCap":1637243793},{"date":"2022-09-02","current":-4.563634,"twenty":-20.369323,"median":-8.440736,"eighty":-4.755115,"marketCap":1717304614},{"date":"2022-09-09","current":-4.935958,"twenty":-20.322864,"median":-8.192539,"eighty":-4.75273,"marketCap":1857411051},{"date":"2022-09-16","current":-6.446532,"twenty":-20.206717,"median":-8.067442,"eighty":-4.789157,"marketCap":2425842882},{"date":"2022-09-23","current":-5.138077,"twenty":-20.029592,"median":-8.012101,"eighty":-4.80566,"marketCap":1933468831},{"date":"2022-09-30","current":-5.287007,"twenty":-19.864082,"median":-7.969059,"eighty":-4.807709,"marketCap":1989511406},{"date":"2022-10-07","current":-5.446575,"twenty":-19.565004,"median":-7.897307,"eighty":-4.808188,"marketCap":2049557022},{"date":"2022-10-14","current":-5.255094,"twenty":-19.474989,"median":-7.850131,"eighty":-4.816442,"marketCap":1977502283},{"date":"2022-10-21","current":-5.648694,"twenty":-19.074281,"median":-7.792746,"eighty":-4.827082,"marketCap":2125614802},{"date":"2022-10-28","current":-6.169948,"twenty":-18.708418,"median":-7.759994,"eighty":-4.837838,"marketCap":2321763814},{"date":"2022-11-04","current":-5.350834,"twenty":-18.432567,"median":-7.688187,"eighty":-4.840172,"marketCap":2013529653},{"date":"2022-11-11","current":-5.850129,"twenty":-18.345457,"median":-7.66161,"eighty":-4.840172,"marketCap":2337775979},{"date":"2022-11-18","current":-5.279141,"twenty":-17.384339,"median":-7.630866,"eighty":-4.848728,"marketCap":2109602638},{"date":"2022-11-25","current":-5.349262,"twenty":-17.09397,"median":-7.608235,"eighty":-4.852475,"marketCap":2137623926},{"date":"2022-12-02","current":-6.240806,"twenty":-16.823928,"median":-7.515551,"eighty":-4.858322,"marketCap":2493894580},{"date":"2022-12-09","current":-6.160667,"twenty":-16.623574,"median":-7.491373,"eighty":-4.90022,"marketCap":2461870251},{"date":"2022-12-16","current":-6.597676,"twenty":-16.559693,"median":-7.481003,"eighty":-4.931988,"marketCap":2636503896},{"date":"2022-12-23","current":-5.593682,"twenty":-16.510331,"median":-7.374505,"eighty":-4.942341,"marketCap":2235296781},{"date":"2022-12-30","current":-5.194133,"twenty":-16.440643,"median":-7.306863,"eighty":-4.940213,"marketCap":2075632726},{"date":"2023-01-06","current":-4.436015,"twenty":-16.359339,"median":-7.212318,"eighty":-4.866558,"marketCap":1772680414},{"date":"2023-01-13","current":-4.897033,"twenty":-16.333207,"median":-7.171327,"eighty":-4.842346,"marketCap":1956908171},{"date":"2023-01-20","current":-4.722871,"twenty":-16.275133,"median":-7.124178,"eighty":-4.829233,"marketCap":1887311019},{"date":"2023-01-27","current":-4.103058,"twenty":-16.260614,"median":-7.060036,"eighty":-4.807722,"marketCap":1639627035},{"date":"2023-02-03","current":-4.436015,"twenty":-16.246096,"median":-7.01344,"eighty":-4.774095,"marketCap":1772680414},{"date":"2023-02-10","current":-3.944263,"twenty":-16.246096,"median":-6.992631,"eighty":-4.723202,"marketCap":1576170807},{"date":"2023-02-17","current":-3.263875,"twenty":-16.20254,"median":-6.972926,"eighty":-4.700167,"marketCap":1304280300},{"date":"2023-02-24","current":-2.744622,"twenty":-16.179311,"median":-6.930371,"eighty":-4.643749,"marketCap":1096781161},{"date":"2023-03-03","current":-2.071586,"twenty":-16.103815,"median":-6.916165,"eighty":-4.599676,"marketCap":862954454},{"date":"2023-03-10","current":-1.506608,"twenty":-16.00509,"median":-6.874287,"eighty":-4.558953,"marketCap":627603239},{"date":"2023-03-17","current":-1.47522,"twenty":-15.92669,"median":-6.834504,"eighty":-4.549413,"marketCap":614528172},{"date":"2023-03-24","current":-1.715859,"twenty":-15.83087,"median":-6.818856,"eighty":-4.528078,"marketCap":714770356},{"date":"2023-03-31","current":-1.904185,"twenty":-15.764085,"median":-6.77547,"eighty":-4.472149,"marketCap":793220761},{"date":"2023-04-06","current":-1.747247,"twenty":-15.735048,"median":-6.723836,"eighty":-4.436015,"marketCap":727845423},{"date":"2023-04-14","current":-2.040199,"twenty":-15.706011,"median":-6.666466,"eighty":-4.416832,"marketCap":849879386},{"date":"2023-04-21","current":-2.395925,"twenty":-15.659552,"median":-6.614841,"eighty":-4.355216,"marketCap":998063485},{"date":"2023-04-28","current":-2.74119,"twenty":-15.446725,"median":-6.58279,"eighty":-4.322356,"marketCap":1141889227},{"date":"2023-05-05","current":-4.049823,"twenty":-15.148947,"median":-6.528777,"eighty":-4.251253,"marketCap":1687022412},{"date":"2023-05-12","current":-2.827879,"twenty":-14.894474,"median":-6.446532,"eighty":-4.251253,"marketCap":1216225460},{"date":"2023-05-19","current":-2.848552,"twenty":-14.785414,"median":-6.425509,"eighty":-4.211866,"marketCap":1225116526},{"date":"2023-05-26","current":-2.412652,"twenty":-14.775027,"median":-6.304447,"eighty":-4.183901,"marketCap":1037643179},{"date":"2023-06-02","current":-2.980335,"twenty":-14.743867,"median":-6.220771,"eighty":-4.163477,"marketCap":1281794515},{"date":"2023-06-09","current":-3.00061,"twenty":-14.691934,"median":-6.20437,"eighty":-4.099937,"marketCap":1290514205},{"date":"2023-06-16","current":-2.828277,"twenty":-14.663371,"median":-6.161604,"eighty":-4.047956,"marketCap":1216396835},{"date":"2023-06-23","current":-2.848552,"twenty":-14.629614,"median":-6.160667,"eighty":-4.037989,"marketCap":1225116526},{"date":"2023-06-30","current":-2.757317,"twenty":-14.619227,"median":-6.081286,"eighty":-4.011813,"marketCap":1185877918},{"date":"2023-07-07","current":-2.666082,"twenty":-14.608841,"median":-5.999743,"eighty":-3.955281,"marketCap":1146639311},{"date":"2023-07-14","current":-2.737043,"twenty":-14.294644,"median":-5.978661,"eighty":-3.888941,"marketCap":1177158228},{"date":"2023-07-21","current":-2.929649,"twenty":-14.164811,"median":-5.925278,"eighty":-3.838093,"marketCap":1259995288},{"date":"2023-07-28","current":-2.440896,"twenty":-14.110281,"median":-5.880833,"eighty":-3.745076,"marketCap":1049790412},{"date":"2023-08-04","current":-2.215663,"twenty":-13.954481,"median":-5.850813,"eighty":-3.591016,"marketCap":952921339},{"date":"2023-08-11","current":-1.672224,"twenty":-13.907741,"median":-5.850471,"eighty":-3.495033,"marketCap":791589180},{"date":"2023-08-18","current":-1.773425,"twenty":-13.863598,"median":-5.829313,"eighty":-3.350979,"marketCap":839495153},{"date":"2023-08-25","current":-1.542109,"twenty":-13.448131,"median":-5.794432,"eighty":-3.263843,"marketCap":729995785},{"date":"2023-09-01","current":-1.551747,"twenty":-13.326088,"median":-5.786986,"eighty":-3.202997,"marketCap":734558259},{"date":"2023-09-08","current":-1.262602,"twenty":-13.258575,"median":-5.744434,"eighty":-3.122256,"marketCap":597684049},{"date":"2023-09-15","current":-1.628852,"twenty":-13.217028,"median":-5.733797,"eighty":-3.041158,"marketCap":771058048},{"date":"2023-09-20","current":-2.524396,"twenty":-13.217028,"median":-5.729693,"eighty":-3.010747,"marketCap":1194985822},{"date":"2023-09-27","current":-2.073107,"twenty":-13.217028,"median":-5.725588,"eighty":-3.00872,"marketCap":981357072},{"date":"2023-10-06","current":-2.08721,"twenty":-13.154708,"median":-5.689852,"eighty":-2.968226,"marketCap":988032970},{"date":"2023-10-13","current":-1.805154,"twenty":-13.076808,"median":-5.652718,"eighty":-2.907056,"marketCap":854515001},{"date":"2023-10-20","current":-1.769898,"twenty":-13.019681,"median":-5.614721,"eighty":-2.88513,"marketCap":837825255},{"date":"2023-10-27","current":-2.891068,"twenty":-13.004101,"median":-5.607928,"eighty":-2.881778,"marketCap":1368559182},{"date":"2023-11-03","current":-5.218025,"twenty":-12.985925,"median":-5.542315,"eighty":-2.887777,"marketCap":2470082426},{"date":"2023-11-10","current":-4.147474,"twenty":-12.983328,"median":-5.514979,"eighty":-2.890675,"marketCap":1899621771},{"date":"2023-11-17","current":-5.962449,"twenty":-12.931394,"median":-5.510402,"eighty":-2.897604,"marketCap":2730914955},{"date":"2023-11-24","current":-6.006183,"twenty":-12.887251,"median":-5.519557,"eighty":-2.901841,"marketCap":2750946116},{"date":"2023-12-01","current":-5.364746,"twenty":-12.850898,"median":-5.531678,"eighty":-2.907056,"marketCap":2457155754},{"date":"2023-12-08","current":-5.044028,"twenty":-12.801561,"median":-5.510527,"eighty":-2.921539,"marketCap":2310260573},{"date":"2023-12-15","current":-5.933293,"twenty":-12.721065,"median":-5.510464,"eighty":-2.929922,"marketCap":2717560847},{"date":"2023-12-22","current":-5.947871,"twenty":-12.669131,"median":-5.52104,"eighty":-2.958695,"marketCap":2724237901},{"date":"2023-12-29","current":-7.595198,"twenty":-12.656148,"median":-5.567998,"eighty":-2.977756,"marketCap":3478744967},{"date":"2024-01-05","current":-7.068919,"twenty":-12.648358,"median":-5.606143,"eighty":-2.977756,"marketCap":3237699159},{"date":"2024-01-12","current":-5.810271,"twenty":-12.645761,"median":-5.634212,"eighty":-2.979819,"marketCap":2661214423},{"date":"2024-01-19","current":-5.312666,"twenty":-12.614601,"median":-5.614721,"eighty":-2.9925,"marketCap":2433301853},{"date":"2024-01-26","current":-4.829696,"twenty":-12.547088,"median":-5.593682,"eighty":-3.006692,"marketCap":2212092593},{"date":"2024-02-02","current":-5.341937,"twenty":-12.492558,"median":-5.520298,"eighty":-3.010747,"marketCap":2446708474},{"date":"2024-02-09","current":-6.307876,"twenty":-12.453608,"median":-5.593682,"eighty":-3.022911,"marketCap":2889126993},{"date":"2024-02-16","current":-6.995742,"twenty":-12.430238,"median":-5.614721,"eighty":-3.061433,"marketCap":3204182605},{"date":"2024-02-23","current":-7.668972,"twenty":-12.409465,"median":-5.641669,"eighty":-3.085762,"marketCap":3512534906},{"date":"2024-03-01","current":-6.922564,"twenty":-12.287422,"median":-5.656743,"eighty":-3.112118,"marketCap":3170666050},{"date":"2024-03-08","current":-7.390899,"twenty":-12.134218,"median":-5.701187,"eighty":-3.15467,"marketCap":3385171999},{"date":"2024-03-15","current":-7.186002,"twenty":-12.105655,"median":-5.729199,"eighty":-3.181485,"marketCap":3291325646},{"date":"2024-03-22","current":-7.130168,"twenty":-12.048528,"median":-5.739116,"eighty":-3.198694,"marketCap":4158285555},{"date":"2024-03-28","current":-6.309679,"twenty":-11.988805,"median":-5.767761,"eighty":-3.208741,"marketCap":3679779437},{"date":"2024-04-05","current":-6.52398,"twenty":-11.905712,"median":-5.794432,"eighty":-3.223115,"marketCap":3804759169},{"date":"2024-04-12","current":-7.034754,"twenty":-11.887535,"median":-5.799755,"eighty":-3.231235,"marketCap":4102640670},{"date":"2024-04-19","current":-5.699776,"twenty":-11.770685,"median":-5.80209,"eighty":-3.263749,"marketCap":3324086748},{"date":"2024-04-26","current":-5.931946,"twenty":-11.562952,"median":-5.80618,"eighty":-3.265036,"marketCap":3459487430},{"date":"2024-05-03","current":-10.41283,"twenty":-11.425329,"median":-5.840175,"eighty":-3.270608,"marketCap":6072720596},{"date":"2024-05-10","current":-9.356456,"twenty":-11.350025,"median":-5.850813,"eighty":-3.286479,"marketCap":5456647492},{"date":"2024-05-17","current":-8.918454,"twenty":-11.246158,"median":-5.860048,"eighty":-3.339097,"marketCap":5359651697},{"date":"2024-05-24","current":-7.687132,"twenty":-11.176049,"median":-5.894887,"eighty":-3.365852,"marketCap":4619673979},{"date":"2024-05-31","current":-7.387932,"twenty":-11.061795,"median":-5.906656,"eighty":-3.409503,"marketCap":4439866309},{"date":"2024-06-07","current":-7.019686,"twenty":-11.061795,"median":-5.916768,"eighty":-3.42283,"marketCap":4218564562},{"date":"2024-06-14","current":-6.858578,"twenty":-10.970912,"median":-5.931853,"eighty":-3.452525,"marketCap":4121745047},{"date":"2024-06-21","current":-8.354577,"twenty":-10.918979,"median":-5.932619,"eighty":-3.488495,"marketCap":5020783396},{"date":"2024-06-28","current":-7.272855,"twenty":-10.802129,"median":-5.962449,"eighty":-3.504025,"marketCap":4370709513},{"date":"2024-07-05","current":-7.318886,"twenty":-10.776162,"median":-5.967829,"eighty":-3.525405,"marketCap":4398372231},{"date":"2024-07-12","current":-7.618086,"twenty":-10.752792,"median":-5.996487,"eighty":-3.551476,"marketCap":4578179901},{"date":"2024-07-19","current":-6.662948,"twenty":-10.674892,"median":-6.006183,"eighty":-3.575448,"marketCap":4004178494},{"date":"2024-07-26","current":-6.45581,"twenty":-10.626408,"median":-6.059073,"eighty":-3.589685,"marketCap":3879696261},{"date":"2024-08-02","current":-5.385595,"twenty":-10.558611,"median":-6.059073,"eighty":-3.624614,"marketCap":3236538057},{"date":"2024-08-09","current":-5.224488,"twenty":-10.468227,"median":-6.006183,"eighty":-3.665485,"marketCap":3139718542},{"date":"2024-08-16","current":-4.673493,"twenty":-10.422117,"median":-5.993231,"eighty":-3.697751,"marketCap":2793099006},{"date":"2024-08-23","current":-4.953203,"twenty":-10.365969,"median":-5.965139,"eighty":-3.736471,"marketCap":2960267026},{"date":"2024-08-30","current":-4.603565,"twenty":-10.233459,"median":-5.947871,"eighty":-3.760134,"marketCap":2751307001},{"date":"2024-09-06","current":-3.939253,"twenty":-10.160753,"median":-5.931946,"eighty":-3.782425,"marketCap":2354282952},{"date":"2024-09-13","current":-4.172345,"twenty":-10.142576,"median":-5.929108,"eighty":-3.818273,"marketCap":2493589636},{"date":"2024-09-20","current":-4.102418,"twenty":-10.121803,"median":-5.916768,"eighty":-3.834832,"marketCap":2451797631},{"date":"2024-09-27","current":-4.580256,"twenty":-10.04086,"median":-5.906656,"eighty":-3.844026,"marketCap":2737376332},{"date":"2024-10-04","current":-3.997526,"twenty":-9.924144,"median":-5.889558,"eighty":-3.85521,"marketCap":2389109623},{"date":"2024-10-11","current":-4.253927,"twenty":-9.81478,"median":-5.85543,"eighty":-3.85521,"marketCap":2542346975},{"date":"2024-10-18","current":-4.137381,"twenty":-9.635322,"median":-5.850813,"eighty":-3.865113,"marketCap":2472693633},{"date":"2024-10-25","current":-6.200245,"twenty":-9.58521,"median":-5.845152,"eighty":-3.869326,"marketCap":3705557783},{"date":"2024-11-01","current":-6.153627,"twenty":-9.545653,"median":-5.850813,"eighty":-3.870615,"marketCap":3677696447},{"date":"2024-11-08","current":-6.49161,"twenty":-9.438984,"median":-5.860749,"eighty":-3.880745,"marketCap":3879691138},{"date":"2024-11-15","current":-5.322907,"twenty":-9.351569,"median":-5.860048,"eighty":-3.906131,"marketCap":3128772519},{"date":"2024-11-22","current":-6.046063,"twenty":-9.335032,"median":-5.864845,"eighty":-3.925768,"marketCap":3553839609},{"date":"2024-11-29","current":-5.974933,"twenty":-9.312017,"median":-5.894887,"eighty":-3.928465,"marketCap":3512029731},{"date":"2024-12-06","current":-5.880093,"twenty":-9.273181,"median":-5.880093,"eighty":-3.940255,"marketCap":3456283228},{"date":"2024-12-13","current":-3.565148,"twenty":-9.252819,"median":-5.860749,"eighty":-3.925768,"marketCap":2095572488},{"date":"2024-12-20","current":-3.254595,"twenty":-9.201669,"median":-5.850813,"eighty":-3.869971,"marketCap":1913031330},{"date":"2024-12-27","current":-3.453349,"twenty":-9.193937,"median":-5.850129,"eighty":-3.85048,"marketCap":2029857671},{"date":"2025-01-03","current":-3.490615,"twenty":-9.132765,"median":-5.829313,"eighty":-3.807761,"marketCap":2051762610},{"date":"2025-01-10","current":-3.006153,"twenty":-9.102707,"median":-5.80209,"eighty":-3.764435,"marketCap":1766998404},{"date":"2025-01-17","current":-3.652103,"twenty":-9.076891,"median":-5.794432,"eighty":-3.697751,"marketCap":2146684012},{"date":"2025-01-24","current":-3.937811,"twenty":-9.007127,"median":-5.786986,"eighty":-3.727867,"marketCap":2314621877},{"date":"2025-01-31","current":-4.285631,"twenty":-8.872423,"median":-5.773398,"eighty":-3.757982,"marketCap":2519067973},{"date":"2025-02-07","current":-4.173832,"twenty":-8.799234,"median":-5.739518,"eighty":-3.764435,"marketCap":2453353156},{"date":"2025-02-14","current":-4.496807,"twenty":-8.788101,"median":-5.733797,"eighty":-3.769191,"marketCap":2643195960},{"date":"2025-02-21","current":-4.248364,"twenty":-8.766864,"median":-5.725977,"eighty":-3.776324,"marketCap":2497163034},{"date":"2025-02-28","current":-4.086877,"twenty":-8.708072,"median":-5.711953,"eighty":-3.764434,"marketCap":2402241632},{"date":"2025-03-07","current":-6.190883,"twenty":-8.688152,"median":-5.725977,"eighty":-3.766814,"marketCap":2560326411},{"date":"2025-03-14","current":-5.922612,"twenty":-8.659753,"median":-5.733797,"eighty":-3.776324,"marketCap":2449378933},{"date":"2025-03-21","current":-5.592431,"twenty":-8.644987,"median":-5.733797,"eighty":-3.781293,"marketCap":2312828191},{"date":"2025-03-28","current":-6.479791,"twenty":-8.614572,"median":-5.734199,"eighty":-3.802816,"marketCap":2679808310},{"date":"2025-04-04","current":-5.840066,"twenty":-8.563776,"median":-5.744434,"eighty":-3.81273,"marketCap":2415241247},{"date":"2025-04-11","current":-5.61192,"twenty":-8.518871,"median":-5.734199,"eighty":-3.827124,"marketCap":2320887960},{"date":"2025-04-17","current":-5.27051,"twenty":-8.465345,"median":-5.734199,"eighty":-3.83157,"marketCap":2179693255},{"date":"2025-04-25","current":-5.569244,"twenty":-8.446639,"median":-5.734602,"eighty":-3.839724,"marketCap":2303238622},{"date":"2025-05-02","current":-5.420577,"twenty":-8.416128,"median":-5.731498,"eighty":-3.85048,"marketCap":2241755640},{"date":"2025-05-09","current":-4.417557,"twenty":-8.366085,"median":-5.725588,"eighty":-3.862304,"marketCap":1826942589},{"date":"2025-05-16","current":-6.127196,"twenty":-8.354577,"median":-5.719055,"eighty":-3.869326,"marketCap":2506641961},{"date":"2025-05-23","current":-5.782002,"twenty":-8.206955,"median":-5.725977,"eighty":-3.869326,"marketCap":2365422696},{"date":"2025-05-30","current":-5.609405,"twenty":-8.183889,"median":-5.717278,"eighty":-3.871904,"marketCap":2294813063},{"date":"2025-06-06","current":-6.256644,"twenty":-8.116751,"median":-5.727588,"eighty":-3.875071,"marketCap":2559599186},{"date":"2025-06-13","current":-6.882308,"twenty":-8.084074,"median":-5.733797,"eighty":-3.885639,"marketCap":2815559104},{"date":"2025-06-20","current":-6.127196,"twenty":-8.072361,"median":-5.736885,"eighty":-3.891073,"marketCap":2506641961},{"date":"2025-06-27","current":-6.019323,"twenty":-8.052684,"median":-5.739948,"eighty":-3.904996,"marketCap":2462510941},{"date":"2025-07-03","current":-5.8683,"twenty":-8.039651,"median":-5.739948,"eighty":-3.917936,"marketCap":2400727512},{"date":"2025-07-11","current":-6.19192,"twenty":-8.033134,"median":-5.744434,"eighty":-3.925541,"marketCap":2533120573},{"date":"2025-07-18","current":-6.105621,"twenty":-8.01579,"median":-5.760427,"eighty":-3.925768,"marketCap":2497815757},{"date":"2025-07-25","current":-6.493965,"twenty":-7.990725,"median":-5.779325,"eighty":-3.930585,"marketCap":2656687431},{"date":"2025-08-01","current":-5.31076,"twenty":-7.981068,"median":-5.766913,"eighty":-3.937811,"marketCap":2172637129},{"date":"2025-08-08","current":-5.786184,"twenty":-7.971528,"median":-5.760427,"eighty":-3.938388,"marketCap":2124061909},{"date":"2025-08-15","current":-6.978197,"twenty":-7.946096,"median":-5.780664,"eighty":-3.941257,"marketCap":2561640196},{"date":"2025-08-22","current":-5.767956,"twenty":-7.910019,"median":-5.782002,"eighty":-3.949772,"marketCap":2117370494},{"date":"2025-08-29","current":-5.999704,"twenty":-7.899359,"median":-5.786585,"eighty":-3.959846,"marketCap":2202443416},{"date":"2025-09-05","current":-6.154203,"twenty":-7.881311,"median":-5.790346,"eighty":-3.962582,"marketCap":2259158697},{"date":"2025-09-12","current":-6.669199,"twenty":-7.856728,"median":-5.794432,"eighty":-3.962656,"marketCap":2448209634},{"date":"2025-09-19","current":-7.338694,"twenty":-7.8463,"median":-5.798504,"eighty":-3.96514,"marketCap":2693975852},{"date":"2025-09-26","current":-6.334452,"twenty":-7.827426,"median":-5.810271,"eighty":-3.975773,"marketCap":2325326525},{"date":"2025-10-03","current":-6.437451,"twenty":-7.812412,"median":-5.822304,"eighty":-3.980017,"marketCap":2363136712},{"date":"2025-10-10","current":-6.282952,"twenty":-7.805489,"median":-5.840066,"eighty":-3.988203,"marketCap":2306421431},{"date":"2025-10-17","current":-6.5147,"twenty":-7.787822,"median":-5.846726,"eighty":-3.998005,"marketCap":2391494353},{"date":"2025-10-24","current":-6.412743,"twenty":-7.77464,"median":-5.850129,"eighty":-3.999922,"marketCap":2354066777},{"date":"2025-10-31","current":-6.332249,"twenty":-7.766384,"median":-5.850813,"eighty":-3.999922,"marketCap":2324517822},{"date":"2025-11-07","current":-5.98976,"twenty":-7.759994,"median":-5.860749,"eighty":-3.999922,"marketCap":2088126179},{"date":"2025-11-14","current":-5.650717,"twenty":-7.710147,"median":-5.861451,"eighty":-4.001057,"marketCap":1969930358},{"date":"2025-11-21","current":-5.707224,"twenty":-7.70248,"median":-5.864845,"eighty":-4.009181,"marketCap":1989629661},{"date":"2025-11-28","current":-6.667846,"twenty":-7.699299,"median":-5.8683,"eighty":-4.009181,"marketCap":2324517822},{"date":"2025-12-05","current":-6.498325,"twenty":-7.689406,"median":-5.870955,"eighty":-4.011287,"marketCap":2265419911},{"date":"2025-12-12","current":-6.187535,"twenty":-7.679723,"median":-5.876746,"eighty":-4.011813,"marketCap":2157073742},{"date":"2025-12-19","current":-5.904999,"twenty":-7.677871,"median":-5.881339,"eighty":-4.019031,"marketCap":2058577224},{"date":"2025-12-26","current":-6.046267,"twenty":-7.672532,"median":-5.881339,"eighty":-4.021875,"marketCap":2107825483},{"date":"2026-01-02","current":-5.59421,"twenty":-7.666027,"median":-5.881339,"eighty":-4.023447,"marketCap":1950231054},{"date":"2026-01-09","current":-6.328803,"twenty":-7.658701,"median":-5.881339,"eighty":-4.027856,"marketCap":2206322000},{"date":"2026-01-16","current":-11.160166,"twenty":-7.674311,"median":-5.891948,"eighty":-4.032863,"marketCap":3890612457},{"date":"2026-01-23","current":-20.738131,"twenty":-7.69623,"median":-5.904137,"eighty":-4.034031,"marketCap":7229644413},{"date":"2026-01-30","current":-16.697869,"twenty":-7.766384,"median":-5.907087,"eighty":-4.037989,"marketCap":5821144207},{"date":"2026-02-06","current":-15.935022,"twenty":-7.812412,"median":-5.912719,"eighty":-4.044079,"marketCap":5555203609},{"date":"2026-02-13","current":-18.703873,"twenty":-7.881311,"median":-5.922612,"eighty":-4.044605,"marketCap":6520469484}],"updateTime":1771087628149},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611160638","title":"ImmunityBio call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2611160638","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611160638?lang=en_us&edition=fundamental","pubTime":"2026-02-14 03:25","pubTimestamp":1771010715,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in ImmunityBio (IBRX) with 40,086 calls trading, 1.1x expected, and implied vol increasing over 3 points to 128.65%. F...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunitybio-call-volume-above-normal-and-directionally-bullish-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunitybio-call-volume-above-normal-and-directionally-bullish-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2609300127","title":"ImmunityBio call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2609300127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609300127?lang=en_us&edition=fundamental","pubTime":"2026-02-06 00:45","pubTimestamp":1770309913,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in ImmunityBio (IBRX) with 31,237 calls trading, 1.5x expected, and implied vol increasing over 4 points to 130.27%. F...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/immunitybio-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/immunitybio-call-volume-above-normal-and-directionally-bullish-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2608848912","title":"BTIG Reaffirms Their Buy Rating on ImmunityBio (IBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2608848912","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608848912?lang=en_us&edition=fundamental","pubTime":"2026-02-03 10:47","pubTimestamp":1770086829,"startTime":"0","endTime":"0","summary":"BTIG analyst Justin Zelin maintained a Buy rating on ImmunityBio yesterday and set a price target of $9.00. According to TipRanks, Zelin is a 4-sta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-immunitybio-ibrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-reaffirms-their-buy-rating-on-immunitybio-ibrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX"],"gpt_icon":0},{"id":"2608065865","title":"ImmunityBio Launches Phase 2 Trial of Chemotherapy-Free CAR-NK Cell Therapy for Indolent Lymphomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2608065865","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608065865?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:02","pubTimestamp":1770033725,"startTime":"0","endTime":"0","summary":"ImmunityBio, Inc. has announced the launch of ResQ215B, a Phase 2 clinical study evaluating a novel, chemotherapy-free and lymphodepletion-free combination immunotherapy for patients with indolent B-cell non-Hodgkin lymphoma , including Waldenstrm's Macroglobulinemia. The outpatient trial investigates the use of ImmunityBio's off-the-shelf CD19-targeted high-affinity natural killer  cell therapy  in combination with nogapendekin-alfa inbakicept , an IL-15 superagonist, and the anti-CD20 monoclonal antibody rituximab. The regimen does not require lymphodepleting chemotherapy or inpatient hospitalization. Initial results from a chemotherapy-free cohort in Waldenstrm's Macroglobulinemia have been reported, with all four patients achieving clinical disease control. Two patients had complete remissions lasting at least 7 and 15 months, while the other two achieved stable disease. Further evaluation of the combination with ANKTIVA will be conducted in the ongoing Phase 2 study.Disclaimer: Th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLbV6g8X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2608654008","title":"Immunitybio Launches Phase 2 Chemotherapy-Free Car-Nk Cell Therapy Trial With Anktiva® (Resq215b) in Indolent Lymphomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2608654008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608654008?lang=en_us&edition=fundamental","pubTime":"2026-02-02 20:00","pubTimestamp":1770033602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA9MTVQK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2608006201","title":"Did ANKTIVA’s Expanding Approvals and Chemo‑Free GBM Data Just Shift ImmunityBio’s (IBRX) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2608006201","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608006201?lang=en_us&edition=fundamental","pubTime":"2026-02-01 09:27","pubTimestamp":1769909248,"startTime":"0","endTime":"0","summary":"In January 2026, ImmunityBio reported expanded enrollment in its Phase 2 QUILT-3.078 glioblastoma trial, updated FDA interactions on a supplemental Biologics License Application for ANKTIVA in papillary non-muscle invasive bladder cancer, and secured Saudi approval for ANKTIVA in bladder cancer carcinoma in situ.\nTogether with very large recent sales growth for ANKTIVA and emerging data on a chemotherapy-free regimen in glioblastoma, these regulatory and clinical steps underscore how...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/did-anktivas-expanding-approvals-and-chemofree-gbm-data-just","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/did-anktivas-expanding-approvals-and-chemofree-gbm-data-just","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2606210162","title":"ImmunityBio Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2606210162","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606210162?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:40","pubTimestamp":1769431200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2026 07:40 ET (12:40 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d291caea2f9e22709bee7595af1065a9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2606175152","title":"ImmunityBio Amends Convertible Note to Allow Partial Debt-to-Equity Conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2606175152","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606175152?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:08","pubTimestamp":1769429326,"startTime":"0","endTime":"0","summary":"ImmunityBio Inc. announced an amendment to its $505 million convertible note with Nant Capital, allowing the noteholder to convert any portion of the debt into company shares before the note matures. No other changes to the agreement were made.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 26, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7CXzFf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2606141882","title":"Analysts Are Bullish on Top Healthcare Stocks: ImmunityBio (IBRX), Brainsway (BWAY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606141882","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606141882?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:20","pubTimestamp":1769426432,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ImmunityBio (IBRX – Research Report), Brainsway (BWA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immunitybio-ibrx-brainsway-bway-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immunitybio-ibrx-brainsway-bway-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRX","XBI","BK4581","BWAY","BK4585","BK4112","LABU","BK4588","LU0128526141.USD","BK4139","BK4082","BK4137","LU0029874061.USD"],"gpt_icon":0},{"id":"2606932297","title":"ImmunityBio Forms Biotech Alliance with Saudi Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2606932297","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606932297?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:54","pubTimestamp":1769414082,"startTime":"0","endTime":"0","summary":"ImmunityBio Inc. has taken part in the USA–Saudi Biotech Alliance Summit, marking the beginning of a new era in healthspan, immunotherapy, and global scientific partnership. This collaboration aims to advance innovative healthcare solutions and foster international cooperation in biotechnology between the United States and Saudi Arabia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief on January 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDLbvtvk7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2606829111","title":"ImmunityBio Reports Promising Survival Data for ANKTIVA Plus CAR-NK in Recurrent Glioblastoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2606829111","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606829111?lang=en_us&edition=fundamental","pubTime":"2026-01-26 14:52","pubTimestamp":1769410361,"startTime":"0","endTime":"0","summary":"ImmunityBio Inc. has announced updated Phase 2 clinical results from the QUILT 3.078 trial  evaluating a chemotherapy-free combination immunotherapy regimen, ANKTIVA plus CAR-NK, in patients with second-line recurrent or progressive glioblastoma  and in patients treated under single-patient INDs across first- to third-line disease. As of January 22, 2026, the primary endpoint of median overall survival has not yet been reached, with 19 of 23 enrolled patients alive. Fourteen patients have evaluable data, with the longest survival from time of disease recurrence reaching 12 months and ongoing. The study reports that baseline mean absolute lymphocyte count  was 0.9 x 10^3/uL, and ALC increased to ≥ 1.4 x 10^3/uL within one treatment cycle . Statistically significant increases in ALC from baseline were observed at all assessments through 20 weeks. Three treatment-related serious adverse events were reported among 41 GBM patients across all cohorts. Randomized controlled trials in both fir","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL7fdycK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2605817406","title":"Immunitybio Shares Down 2% After Co Reports Mid-Stage Data for Brain Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2605817406","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605817406?lang=en_us&edition=fundamental","pubTime":"2026-01-23 22:38","pubTimestamp":1769179100,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nFWN3YO02P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2605340894","title":"BUZZ-ImmunityBio releases early brain cancer treatment trial data; shares down","url":"https://stock-news.laohu8.com/highlight/detail?id=2605340894","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605340894?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:27","pubTimestamp":1769174849,"startTime":"0","endTime":"0","summary":"BUZZ-ImmunityBio releases early brain cancer treatment trial data; shares down** Shares of drug developer ImmunityBio IBRX.O fall 3% to $7.13 premarket ** Co says 19 of 23 patients in its ongoing study for recurrent glioblastoma, an aggressive brain cancer, remain alive after treatment, with median survival not yet reached ** Co says its experimental chemo-free combo of Anktiva and CARNK cells aims to help the immune system fight the tumor** Anktiva is an immuneactivating protein and part of a chemofree combo being tested in recurrent glioblastoma     ** Patients showed improved immune cell counts after one treatment cycle - IBRX** IBRX fell ~23% in 2025","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nL4N3YO16M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRX"],"gpt_icon":1},{"id":"2605785472","title":"BRIEF-ImmunityBio: Median Overall Survival Unreached, Lymphopenia Reversed In Recurrent Glioblastoma On Anktiva And CAR-NK Chemo-Free Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605785472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605785472?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:09","pubTimestamp":1769170190,"startTime":"0","endTime":"0","summary":"BRIEF-ImmunityBio: Median Overall Survival Unreached, Lymphopenia Reversed In Recurrent Glioblastoma On Anktiva And CAR-NK Chemo-Free TherapyJan 23 (Reuters) - Immunitybio Inc IBRX.O:IMMUNITYBIO REPOR","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nTUA9B2XYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2605472976","title":"Immunitybio Inc: Three Participants Experienced Serious Adverse Events Suspected to Be Related to Experimental Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605472976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605472976?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:00","pubTimestamp":1769169601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nTUA9B2XYV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2605472970","title":"Immunitybio Inc: Treatment Regimen Demonstrated a Manageable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2605472970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605472970?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:00","pubTimestamp":1769169601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nTUA9B2XYV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2605472644","title":"Immunitybio Reports Median Overall Survival Not yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving Anktiva® Plus Car-Nk, Chemo-Free Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2605472644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605472644?lang=en_us&edition=fundamental","pubTime":"2026-01-23 20:00","pubTimestamp":1769169601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260123:nTUA9B2XYV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2605476739","title":"ImmunityBio Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2605476739","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605476739?lang=en_us&edition=fundamental","pubTime":"2026-01-23 18:18","pubTimestamp":1769163480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2026 05:18 ET (10:18 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d2fa05b1acaa81e4990ac1a3b421573e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2605144907","title":"A Look At ImmunityBio (IBRX) Valuation After FDA Anktiva Pathway And Saudi Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=2605144907","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605144907?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:38","pubTimestamp":1769121494,"startTime":"0","endTime":"0","summary":"ImmunityBio (IBRX) is back in focus after the FDA outlined a path to resubmit its Anktiva supplemental biologics filing for papillary bladder cancer without new trials, alongside fresh approvals in Saudi Arabia.\nSee our latest analysis for ImmunityBio.\nThe recent FDA feedback and Saudi approvals came on top of a powerful run, with a 30-day share price return of 248.81% and a year to date share price return of 262.62%. The 1-year total shareholder return of 134.78% and 3-year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/a-look-at-immunitybio-ibrx-valuation-after-fda-anktiva-pathw","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ibrx/immunitybio/news/a-look-at-immunitybio-ibrx-valuation-after-fda-anktiva-pathw","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBRX","BK4139","DCF"],"gpt_icon":1},{"id":"2605443011","title":"ImmunityBio Director Christobel Selecky Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605443011","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605443011?lang=en_us&edition=fundamental","pubTime":"2026-01-22 09:34","pubTimestamp":1769045665,"startTime":"0","endTime":"0","summary":"Christobel Selecky, Director at ImmunityBio, Inc., has reported a disposal of common shares of ImmunityBio Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunitybio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 21, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDLCDKh2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ImmunityBio Director Christobel Selecky Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX","BK4139"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":122,"code":"91000000","status":"200"}]}}